Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines.
Saved in:
| Title: | Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines. |
|---|---|
| Authors: | Russell CA; Department of Medical Microbiology & Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Fouchier RAM; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands., Ghaswalla P; Moderna, Inc., Cambridge, MA, USA., Park Y; Moderna, Inc., Cambridge, MA, USA., Vicic N; Moderna, Inc., Cambridge, MA, USA., Ananworanich J; Moderna, Inc., Cambridge, MA, USA., Nachbagauer R; Moderna, Inc., Cambridge, MA, USA., Rudin D; Moderna, Inc., Cambridge, MA, USA. |
| Source: | Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2336357. Date of Electronic Publication: 2024 Apr 15. |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38619079 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Russell+CA%22">Russell CA</searchLink>; Department of Medical Microbiology & Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Fouchier+RAM%22">Fouchier RAM</searchLink>; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Ghaswalla+P%22">Ghaswalla P</searchLink>; Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Park+Y%22">Park Y</searchLink>; Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Vicic+N%22">Vicic N</searchLink>; Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ananworanich+J%22">Ananworanich J</searchLink>; Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Nachbagauer+R%22">Nachbagauer R</searchLink>; Moderna, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rudin+D%22">Rudin D</searchLink>; Moderna, Inc., Cambridge, MA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101572652%22">Human vaccines & immunotherapeutics</searchLink> [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2336357. <i>Date of Electronic Publication: </i>2024 Apr 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101572652 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2164-554X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221645515%22">21645515 </searchLink><i>NLM ISO Abbreviation: </i>Hum Vaccin Immunother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38619079 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/21645515.2024.2336357 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2336357 Titles: – TitleFull: Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Russell CA – PersonEntity: Name: NameFull: Fouchier RAM – PersonEntity: Name: NameFull: Ghaswalla P – PersonEntity: Name: NameFull: Park Y – PersonEntity: Name: NameFull: Vicic N – PersonEntity: Name: NameFull: Ananworanich J – PersonEntity: Name: NameFull: Nachbagauer R – PersonEntity: Name: NameFull: Rudin D IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 12 Text: 2024 Dec 31 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2164-554X Numbering: – Type: volume Value: 20 – Type: issue Value: 1 Titles: – TitleFull: Human vaccines & immunotherapeutics Type: main |
| ResultId | 1 |